Tzeng; Cherng-Chyi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tzeng; Cherng-Chyi.The latest application filed is for "neutrophil inflammation inhibitor and uses thereof".

Company Profile

4.25.26

Tzeng; Cherng-Chyi - Kaohsiung TW
TZENG; Cherng-Chyi - Kaohsiung City TW
Tzeng; Cherng-Chyi - Taipei N/A TW
TZENG; Cherng-Chyi - Taipei City TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazolo[4,3-c]quinoline derivatives for inhibition of .beta.-glucuronidase Grant 11,135,206 - Chen , et al. October 5, 2	2021-10-05
Pyrazolo[4,3-C] quinoline derivatives for inhibition of .beta.-glucuronidase Grant 11,052,072 - Chen , et al. July 6, 2	2021-07-06
Neutrophil inflammation inhibitor and uses thereof Grant 10,654,848 - Hwang , et al.	2020-05-19
Neutrophil Inflammation Inhibitor And Uses Thereof App 20200148674 - HWANG; Tsong-Long ; et al.	2020-05-14
PYRAZOLO[4,3-C]Quinoline Derivatives For Inhibition Of Beta-Glucuronidase App 20200113878 - Chen; Yeh-Long ; et al.	2020-04-16
Pyrazolo[4,3-c]quinoline Derivatives For Inhibition Of Beta-glucuronidase App 20180214426 - Chen; Yeh-Long ; et al.	2018-08-02
Conformations of divergent peptides with mineral binding affinity Grant 9,415,114 - Chen , et al. August 16, 2	2016-08-16
Conformations of divergent peptides with mineral binding affinity Grant 9,314,533 - Chen , et al. April 19, 2	2016-04-19
Sustained release systems and preparation method thereof Grant 9,314,503 - Fu , et al. April 19, 2	2016-04-19
Conformations Of Divergent Peptides With Mineral Binding Affinity App 20150320876 - Chen; Hui-Ting ; et al.	2015-11-12
4-anilinofuro[2,3-b]quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same Grant 8,952,033 - Tzeng , et al. February 10, 2	2015-02-10
Conformations Of Divergent Peptides With Mineral Binding Affinity App 20140377212 - Chen; Hui-Ting ; et al.	2014-12-25
Conformations of divergent peptides with mineral binding affinity Grant 8,889,828 - Chen , et al. November 18, 2	2014-11-18
Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel Grant 8,883,862 - Ho , et al. November 11, 2	2014-11-11
Method for controlled release of parathyroid hormone from encapsulated poly(lactic-glycolic)acid microspheres Grant 8,865,220 - Ho , et al. October 21, 2	2014-10-21
Controlled release system and manufacturing method thereof Grant 8,663,677 - Fu , et al. March 4, 2	2014-03-04
Quinoline derivatives and uses of the same Grant 8,552,029 - Hwa , et al. October 8, 2	2013-10-08
Method For Controlled Release Of Parathyroid Hormone From Cross-linked Hyaluronic Acid Hydrogel App 20130183349 - Ho; Mei-Ling ; et al.	2013-07-18
4-anilinofuro[2,3-b]quinoline Derivatives, Their Preparation Processes, And Pharmaceutical Compositions Comprising The Same App 20130172336 - Tzeng; Cherng-Chyi ; et al.	2013-07-04
Hyaluronic Acid Hydrogel And Use Thereof App 20130171197 - Ho; Mei-Ling ; et al.	2013-07-04
Quinoline Derivatives And Uses Of The Same App 20130096157 - HWA; Kuo-Yuan ; et al.	2013-04-18
Conformations Of Divergent Peptides With Mineral Binding Affinity App 20120270811 - Chen; Hui-Ting ; et al.	2012-10-25
Indolo[3,2-c]quinoline compounds Grant 8,273,760 - Tzeng , et al. September 25, 2	2012-09-25
Isoxazole derivatives and pharmaceutical compositions comprising the same Grant 8,138,184 - Tzeng , et al. March 20, 2	2012-03-20
Nanoparticles and Use Thereof App 20110318331 - Wang; Chih-Kuang ; et al.	2011-12-29
Controlled Release System And Manufacturing Method Thereof App 20110312885 - Fu; Yin-Chih ; et al.	2011-12-22
Method for Controlled Release of Parathyroid Hormone from Encapsulated Poly(Lactic-Glycolic)Acid Microspheres App 20110305766 - Ho; Mei-Ling ; et al.	2011-12-15
Sustained Release Systems and Preparation Method Thereof App 20110052691 - Fu; Yin-Chin ; et al.	2011-03-03
Indolo[3,2-c]quinoline Compounds App 20100286163 - Tzeng; Cherng-Chyi ; et al.	2010-11-11
Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same Grant 7,829,567 - Tzeng , et al. November 9, 2	2010-11-09
Indolo[3,2-c]quinoline compounds Grant 7,763,633 - Tzeng , et al. July 27, 2	2010-07-27
Indolo[3,2-c]quinoline Compounds App 20090298846 - TZENG; CHERNG-CHYI ; et al.	2009-12-03
Isoflavone derivatives and pharmaceutical compositions comprising the same Grant 7,618,998 - Tzeng , et al. November 17, 2	2009-11-17
Isoxazole Derivatives And Pharmaceutical Compositions Comprising The Same App 20090215768 - Tzeng; Cherng-Chyi ; et al.	2009-08-27
Isoflavone Derivatives And Pharmaceutical Compositions Comprising The Same App 20090215767 - TZENG; Cherng-Chyi ; et al.	2009-08-27
Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same App 20090111987 - Tzeng; Cherng-Chyi ; et al.	2009-04-30
Controlled release system and manufacturing method thereof App 20080220070 - Fu; Yin-Chih ; et al.	2008-09-11
4-Anilino[2,3-b]quinoline derivatives, their preparation processes and pharmaceutical compositions comprising the same Grant 6,750,223 - Tzeng June 15, 2	2004-06-15
4-ANILINO[2,3-b]QUINOLINE DERIVATIVES,THEIR PREPARATION PROCECC ANDPHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME App 20040072856 - Tzeng, Cherng-Chyi	2004-04-15
6-fluoro-1,4-dihydro-7-[4-(2-hydroxyiminoethyl)-1-piperazinyl]-4-oxoquinol- ine-3-carboxylic acid derivatives, their preparation and pharmaceutical compositions App 20020061895 - Tzeng, Cherng-Chyi ; et al.	2002-05-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.